Back

Evaluation Of The Safety And Tolerability Of Exogenous Ketosis Induced By Orally Administered Free Beta-Hydroxybutyrate In Healthy Adult Subjects

Pimentel-Suarez, L. I.; Soto-Mota, L. A.

2023-06-20 pharmacology and therapeutics
10.1101/2023.06.12.23291298
Show abstract

Beta-hydroxybutyrate (D-BHB) is a metabolite with intrinsic signalling activity that has gained attention as a potentially clinically useful supplement. There are available supplements for inducing ketosis: ketone salts, ketone esters, and medium-chain triglycerides. Even when all of them raise the beta-hydroxybutyrate in the blood and all are safe and well tolerated, they significantly differ in their safety profile, their palatability, and their price. A fourth and potentially interesting option is to use biologically identical beta-hydroxybutyrate, while it is already commercially available in the United States (American Ketone LLC) and Greater China (MedPHA Ltd). However, its safety and tolerability had not yet been documented in the scientific literature. We evaluated the safety and tolerability of orally administered Free D-BHB in a gender and age-balanced sample of 24 asymptomatic and overtly healthy adults. No participant showed acid-base abnormalities or electrolyte abnormalities. Secondary symptoms were reported after only 6.2% of all drink takes and none of the reports described the symptom as "severe". The most frequently reported secondary effects (19/720 or 2.6%) were gastrointestinal discomfort, headache (7/720 or 1%), and loss of appetite (7/720 or 1%). No correlation between weight-adjusted dose and frequency of secondary symptoms was observed. Free D-BHB was a safe and well-tolerated intervention for inducing sustained exogenous ketosis. Being bio-identical, salt-free, and lacking intermediate metabolites, this form of supplementation could have a larger safety spectrum than salt or alcohol-based exogenous ketones. More research is warranted to assess its clinical efficacy in those clinical scenarios in which achieving ketosis rapidly could be beneficial. KEY MESSAGESO_ST_ABSWhat is already known on this topicC_ST_ABS- Ketogenic supplements could be useful therapeutic tools in certain time-sensitive circumstances. A previously unexplored but attractive option is using bio-identical D-BHB. What this study adds- Diluted Free D-BHB is a safe and well-tolerated intervention for inducing sustained exogenous ketosis. How this study might affect research, practice, or policy- Being bio-identical, salt-free, further research is warranted on the potential clinical uses of Free-BHB.

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Clinical Pharmacology & Therapeutics
based on 19 papers
Top 0.3%
11.5%
2
BMJ Nutrition, Prevention & Health
based on 10 papers
Top 0.1%
10.5%
3
Scientific Reports
based on 701 papers
Top 21%
7.8%
4
British Journal of Clinical Pharmacology
based on 21 papers
Top 0.3%
7.8%
5
PLOS ONE
based on 1737 papers
Top 56%
7.8%
6
Clinical and Translational Science
based on 14 papers
Top 0.1%
6.0%
50% of probability mass above
7
Diabetes, Obesity and Metabolism
based on 14 papers
Top 0.2%
6.0%
8
Frontiers in Pharmacology
based on 27 papers
Top 0.5%
5.5%
9
Cureus
based on 64 papers
Top 4%
4.6%
10
GeroScience
based on 22 papers
Top 0.9%
1.9%
11
Heliyon
based on 57 papers
Top 5%
1.6%
12
Journal of Clinical Medicine
based on 77 papers
Top 9%
1.6%
13
JMIRx Med
based on 29 papers
Top 2%
1.6%
14
Frontiers in Psychiatry
based on 56 papers
Top 5%
1.6%
15
Frontiers in Medicine
based on 99 papers
Top 13%
1.4%
16
Current Developments in Nutrition
based on 11 papers
Top 1%
1.2%
17
Pilot and Feasibility Studies
based on 12 papers
Top 1%
1.2%
18
Obesity
based on 11 papers
Top 2%
0.8%
19
BMJ Open
based on 553 papers
Top 49%
0.8%
20
Frontiers in Nutrition
based on 13 papers
Top 2%
0.8%
21
The Journal of Nutrition
based on 11 papers
Top 1%
0.8%
22
Trials
based on 24 papers
Top 3%
0.8%
23
BJPsych Open
based on 24 papers
Top 2%
0.8%
24
BJGP Open
based on 12 papers
Top 2%
0.7%
25
PeerJ
based on 46 papers
Top 12%
0.7%
26
Atherosclerosis
based on 16 papers
Top 4%
0.7%
27
International Journal of Molecular Sciences
based on 39 papers
Top 4%
0.7%
28
Nutrients
based on 43 papers
Top 5%
0.7%